Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorMarquez-Rodas, I.
dc.contributor.authorArance, A.
dc.contributor.authorBerciano Guerrero, M. A.
dc.contributor.authorDiaz Beveridge, R.
dc.contributor.authorAlamo, M. D. C.
dc.contributor.authorGarcia Castano, A.
dc.contributor.authorGonzalez Cao, M.
dc.contributor.authorVidal, J.
dc.contributor.authorPuertolas Hernandez, T.
dc.contributor.authorSoria, A.
dc.contributor.authorAguado De la Rosa, C.
dc.contributor.authorSanchez Maurino, P.
dc.contributor.authorValduvieco, I.
dc.contributor.authorDelgado Rico, R.
dc.contributor.authorConde, A.
dc.contributor.authorForo, P.
dc.contributor.authorPrada, P. J.
dc.contributor.authorPuertas, E.
dc.contributor.authorAlvarez Gonzalez, A.
dc.contributor.authorBerrocal, A.
dc.contributor.authoraffiliation[Marquez-Rodas, I.] Hosp Gen Univ Gregorio Maranon, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Arance, A.] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Arance, A.] IDIBAPS, Barcelona, Spain
dc.contributor.authoraffiliation[Berciano Guerrero, M. A.] Unidad Intercentros Oncol HURyVV, Med Oncol, Hosp Univ Reg & Virgen Vic, Inst Invest Biomed Malaga,Malaga IBIMA, Malaga, Spain
dc.contributor.authoraffiliation[Diaz Beveridge, R.] Hosp Univ & Politecn La Fe, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Alamo, M. D. C.] Hosp Univ Virgen Macarena, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Garcia Castano, A.] Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain
dc.contributor.authoraffiliation[Gonzalez Cao, M.] Hosp Univ Dexeus, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Vidal, J.] Hosp Mar IMIM, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Puertolas Hernandez, T.] Hosp Miguel Servet, Dept Med Oncol, Zaragoza, Spain
dc.contributor.authoraffiliation[Soria, A.] Hosp Univ Ramon y Cajal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Aguado De la Rosa, C.] Hosp Clin San Carlos, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Sanchez Maurino, P.] Hosp Univ Reina Sofia, Med Oncol, Cordoba, Spain
dc.contributor.authoraffiliation[Valduvieco, I.] Hosp Clin Barcelona, Radiat Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Valduvieco, I.] IDIBAPS, Barcelona, Spain
dc.contributor.authoraffiliation[Delgado Rico, R.] Hosp Univ Reg Malaga, Radiat Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Conde, A.] Hosp Univ & Politecn La Fe, Radiat Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Foro, P.] Hosp Mar IMIM, Radiat Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Foro, P.] Univ Pompeu Fabra, Barcelona, Spain
dc.contributor.authoraffiliation[Prada, P. J.] Hosp Univ Marques Valdecilla, Radiat Oncol, Santander, Spain
dc.contributor.authoraffiliation[Puertas, E.] Hosp Univ Dexeus, Radiat Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Alvarez Gonzalez, A.] Hosp Gen Univ Gregorio Maranon, Radiat Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Berrocal, A.] Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain
dc.contributor.funderPierre Fabre
dc.date.accessioned2025-01-07T13:48:47Z
dc.date.available2025-01-07T13:48:47Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1423
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.1423
dc.identifier.urihttps://hdl.handle.net/10668/25882
dc.identifier.wosID700527702057
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS870-S870
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleIntracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía